TradingGainTradingGainNEWS
📊 Data ▾
Get the appApp
Loading live prices…
↑ New stories · tap to refresh
Regulation● Neutral

Intel, Oracle and IBM Among 26 Firms Opposing OKX-ICE Tokenized Stock Plans

TradingGain NewsroomTradingGain Newsroom··27 Oct 2026, 18:13 UTC

Intel, Oracle and IBM have joined a growing list of companies objecting to tokenized stock plans from the OKX and ICE joint venture. A newer notice added four more objections, bringing the total to 26. The venture is preparing to test the SEC's new framework for blockchain-based stock trading, which may shape how tokenized stocks are offered.

Why it matters

  • Four new objections raised the total number of opposing firms to 26.
  • The OKX–ICE venture is preparing to test the SEC's new framework for blockchain-based stock trading.
  • Regulatory clarity on tokenized stocks may affect which products traders can access in the future.

What to watch next

Watch how the OKX–ICE venture's test of the SEC framework goes and whether more firms add objections.

This brief is written by TradingGain from public reporting by CoinDesk.Read original ↗
Intel, Oracle and IBM Among 26 Firms Opposing OKX-ICE Tokenized Stock Plans
Story card · share it on your status or channel⬇ Download image

More stories

All news →
Market Data▲ Bullish● Important

IDOL rallies 53.8% in 24 hours on heavy volume

IDOL is one of the biggest movers among the most traded coins today, up 53.8% to $0.013011 with $200.0M traded in 24 hours. Moves this large usually come with big swings in both directions, so manage risk carefully.

Market Data▲ Bullish

Q funding hits −0.075%: shorts are crowded

The funding rate on Q perpetual futures is −0.075% per 8 hours, which means short traders are paying a lot to keep their positions open. Very crowded positioning like this can end with a sharp move higher (short squeeze).

TradingGain News summarises public reports in our own words and always links to the original source. Market Data stories are generated automatically from public exchange data. Nothing on this page is financial advice; always do your own research and use a stop-loss.